Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-06-13

FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company. This action represents a supplemental FDA approval related…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epivir (Lamivudine)

Snippet

SUPPL AP for EPIVIR (LAMIVUDINE)